NCT06853756 Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia
| NCT ID | NCT06853756 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Gastric Insufflation |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2025-03-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-08-01 with a primary completion date of 2025-03-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our study aimed to compare the gastric insufflation volume between Ambu AuraGain and i-gel and its relationship with the oropharyngeal sealing pressure and the incidence of postoperative complications in generally anesthetized controlled-ventilated pediatric patients undergoing elective orthopedic operations.
Eligibility Criteria
Inclusion Criteria: * Aged from 2 to 12 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I and II. * Scheduled for elective orthopedic operations in a supine position under general anesthesia. Exclusion Criteria: * Patients with a known history of gastro-oesophageal reflux disorders. * Full Stomach. * Anticipated difficult mask ventilation or intubation. * Body mass index "BMI" exceeding 20% of the ideal. * A history of chest problems. * History of the gastrointestinal tract or thoracic surgeries.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06853756 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 12 Years, studying Gastric Insufflation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06853756 currently recruiting?
Yes, NCT06853756 is actively recruiting participants. Contact the research team at aya.nabil311.nabil@gmail.com for enrollment information.
Where is the NCT06853756 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06853756 clinical trial?
NCT06853756 is sponsored by Tanta University. The trial plans to enroll 60 participants.